Effects of Inspiratory Muscle Exercise on Health

NCT ID: NCT07095179

Last Updated: 2026-02-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-03-01

Study Completion Date

2027-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate whether inspiratory muscle training has an immediate effect on energy expenditure, heart rate, blood glucose, blood pressure, and arterial stiffness in healthy adults, obese adults, and adults with type 2 diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be asked to complete two trials involving intermittent exercise, which will include eupnea and inspiratory muscle training (IMT), as well as a resting control condition, in a randomized crossover study design. The trials will be separated by a minimum of 48 hours and will be completed within a 7-day period. Throughout all trials, participants will be required to remain relaxed and seated on an adjustable examination bed. For the IMT intensity, participants will utilize an inspiratory muscle training device (PowerBreathe Plus, Powerbreathe International Ltd., UK) and adjust the resistance to a level at which breathing continuously for 20 breaths is perceived as "somewhat hard" (RPE = 13), according to the Rating of Perceived Exertion (RPE) scale. This will take place during a 3.5-hour oral glucose tolerance test (OGTT). During the trials, participants may watch television or read; however, typing on a laptop or computer will be prohibited.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intermittent Inspiratory Muscle Training Eupnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eupnea

Participants will breathe normally.

Group Type EXPERIMENTAL

Eupnea

Intervention Type BEHAVIORAL

Participants will breathe normally.

Inspiratory muscle training

Intermittent inspiratory muscle training (IMT) will be conducted throughout the trial

Group Type EXPERIMENTAL

Intermittent inspiratory muscle training (IIMT)

Intervention Type BEHAVIORAL

Intermittent inspiratory muscle training (IIMT) will be conducted throughout the trial

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eupnea

Participants will breathe normally.

Intervention Type BEHAVIORAL

Intermittent inspiratory muscle training (IIMT)

Intermittent inspiratory muscle training (IIMT) will be conducted throughout the trial

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adults, obese adults and adults with type 2 diabetes
* Aged between 20 to 45 years
* Weight stable for more than 3 months (no change in weight +/- 3%)
* Non-smoker
* Non-highly trained athletic team members
* Normal lifestyle patterns

Exclusion Criteria

* Personal history of/existing hypertension, respiratory infectious disease, cardiovascular disease, metabolic disease
* Taking medications that may influence lipid or carbohydrate metabolism or immune system function
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan Normal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yung-Chih Chen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yung-Chih Chen, PhD

Role: CONTACT

02-77496979

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202506HM022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.